Subtype
Spinal Cord Neoplasm
CI-CAN-00001540Explore in graph →
Non-malignant7 active trials1 evidence items
Loading cancer entity…
Subtype
CI-CAN-00001540Explore in graph →
Clinical trials
54 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01236560 | Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma | completed | Phase 2 / Phase 3 | 101 | National Cancer Institute (NCI)NIH | 2 | Feb 20, 2024 | clinicaltrials |
| NCT05096468 | Esketamine Combined With Pregabalin on Acute Postoperative Pain in Patients Undergoing Resection of Spinal Neoplasms. | completed | Phase 2 / Phase 3 | 90 | Beijing Tiantan HospitalOTHER | 1 | Jul 6, 2023 |
| clinicaltrials |
| NCT05493228 | Dexmedetomidine Infusion on Intraoperative Propofol,Fentanyl Requirements in Spine Surgery for Pediatric Cancer Patients | unknown | Phase 3 | 38 | Children's Cancer Hospital Egypt 57357OTHER | 1 | Aug 9, 2022 | clinicaltrials |
Data updated 22 days agoSource updated Feb 20, 2024source: clinicaltrials